Coot, Merinda B.
HRN: 29-11-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/28/2026
07/05/2026
IV
600mg
Q8
Sacral Ulcer
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines